• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2010 Fiscal Year Final Research Report

Regulation of macrophage foam cell formation and atherosclerosis by novel regulatory peptides for cardiovascular system

Research Project

  • PDF
Project/Area Number 20591084
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionShowa University

Principal Investigator

MIYAZAKI Akira  Showa University, 医学部, 教授 (70253721)

Co-Investigator(Kenkyū-buntansha) WATANABE Takuya  東京薬科大学, 生命科学部, 教授 (30297014)
HIRANO Tsutomu  昭和大学, 医学部, 教授 (00167610)
Co-Investigator(Renkei-kenkyūsha) SHICHIRI Masayoshi  北里大学, 医学部, 教授 (10206097)
Project Period (FY) 2008 – 2010
Keywords動脈硬化 / 血管作動性物質 / マクロファージ / 高血圧
Research Abstract

Continuous subcutaneous infusion of urotensin II, a strong vasoconstrictor peptide, enhanced atherosclerotic lesions by 8-fold in fat-fed apoE-knockout mice. Analyses of peritoneal macrophages from urotensin II-treated mice revealed 7-fold increase in foam cell formation induced by oxidized LDL. Salusins are novel vasoregulatory peptides that derive from the same precursor. Development of atherosclerosis in apoE-KO mice was suppressed by 68% by continuous subcutaneous infusion of salusin-α but was 2.6-fold enhanced by salusin-β. Peritoneal macrophages from salusin?α-treated mice revealed 68% reduction in foam cell formation induced by oxidized LDL whereas macrophages from salusin-β-treated mice showed 2.6-fold increase in foam cell formation. Thus, urotensin II and salusins can be regarded as novel therapeutic targets for atherosclerosis.

  • Research Products

    (20 results)

All 2010 2009 2008

All Journal Article (9 results) (of which Peer Reviewed: 9 results) Presentation (11 results)

  • [Journal Article] Chronic infusin of salusin-α and salusin-β exerts opposite effects on atherosclerostic lesion development in apolipoprotein E-deficient mice.2010

    • Author(s)
      Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T
    • Journal Title

      Atherosclerosis 212(1)

      Pages: 70-77

    • Peer Reviewed
  • [Journal Article] A selective ACAT-1 inhibitor, K-604, stimulates collagen production in cultured smooth muscle cells and alters plaque phenotype in apolipoprotein E-knockout mice.2010

    • Author(s)
      Yoshinaka Y, Shibata H, Kobayashi H, Kuriyama H, Shibuya K, Tanabe S, Watanabe T, Miyazaki A
    • Journal Title

      Atherosclerosis 213(1)

      Pages: 85-91

    • Peer Reviewed
  • [Journal Article] Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.2009

    • Author(s)
      Ban Y, Watanabe T, Suguro T, Matsuyama T, Iso Y, Sakai T, Sato R, Idei T, Nakano Y, Ota H, Miyazaki A, Kato N, Hirano T, Ban Y, Kobayashi Y
    • Journal Title

      Journal of Atherosclerosis and Thrombosis 16(3)

      Pages: 179-187

    • Peer Reviewed
  • [Journal Article] Leptin modulates ACAT-1 expression and cholesterol efflux from human macrophages.2009

    • Author(s)
      Hongo S, Watanabe T, Arita S, Kanome T, Kageyama H, Shioda S, Miyazaki A
    • Journal Title

      American Journal of Physiology, Endocrinology and Metabolism 297(2)

      Pages: E474-482

    • Peer Reviewed
  • [Journal Article] Preventive effects of heregulin-β1 on macrophage foam cell formation and atherosclerosis.2009

    • Author(s)
      Xu G, Watanabe T, Iso Y, Koba S, Sakai T, Nagashima M, Arita S, Hongo S, Ota H, Kobayashi Y, Miyazaki A, Hirano T
    • Journal Title

      Circulation Research 105(5)

      Pages: 500-510

    • Peer Reviewed
  • [Journal Article] Human Urotensin II promotes hypertension and atherosclerotic cardiovascular diseases (review).2009

    • Author(s)
      Watanabe T, Arita S, Shiraishi Y, Suguro T, Sakai T, Hongo S, Miyazaki A
    • Journal Title

      Current Medicinal Chemistry 16(5)

      Pages: 550-563

    • Peer Reviewed
  • [Journal Article] Angiotensin II upregulates acyl-CoA : cholesterol acyltransferase-1 via AT1 receptor in human monocyte-macrophages.2008

    • Author(s)
      Kanome T, Watanabe T, Nishio K, Takahashi K, Hongo S, Miyazaki A
    • Journal Title

      Hypertension Research 31(9)

      Pages: 1801-1810

    • Peer Reviewed
  • [Journal Article] Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.2008

    • Author(s)
      Shiraishi Y, Watanabe T, Suguro T, Kato R, Hongo S, Itabe H, Miyazaki A, Hirano T, Adachi M
    • Journal Title

      Journal of Hypertension 26(10)

      Pages: 1955-1965

    • Peer Reviewed
  • [Journal Article] Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in type 2 diabetes mellitus.2008

    • Author(s)
      Suguro T, Watanabe T, Kodate S, Xu G, Hirano T, Adachi M, Miyazaki A
    • Journal Title

      Clinical Science 115(11)

      Pages: 327-334

    • Peer Reviewed
  • [Presentation] Preventive effects of heregulin-β1 on macrophage foam cell formation and atherosclerosis.2010

    • Author(s)
      渡部琢也・有田茂子・長嶋理晴・平野勉・宮崎章・他
    • Organizer
      第42回日本動脈硬化学会学術集会
    • Place of Presentation
      岐阜
    • Year and Date
      20100700
  • [Presentation] Opposite effects of salusins on the development of atherosclerotic plaques.2009

    • Author(s)
      Watanabe T, Nagashima M, Arita S, Hongo S, Shichiri M, Hirano T, Miyazaki A
    • Organizer
      American Heart Association Scientific Sessions 2009
    • Place of Presentation
      Orlando
    • Year and Date
      20091100
  • [Presentation] Chronic infusion of salusin-α and -β exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-knockout mice.2009

    • Author(s)
      長嶋理晴・渡部琢也・宮崎 章・平野勉
    • Organizer
      第41回日本動脈硬化学会学術集会
    • Place of Presentation
      下関
    • Year and Date
      20090700
  • [Presentation] ヒトマクロファージからのコレステロール搬出に対するレプチンの抑制作用2009

    • Author(s)
      本郷茂樹・渡部琢也・有田茂子・金山朱里・宮崎章
    • Organizer
      第51回日本脂質生化学会
    • Place of Presentation
      名古屋
    • Year and Date
      20090700
  • [Presentation] 新規血管作動性物質サリューシンαおよびβのマクロファージ泡沫化および動脈硬化に対する相反作用2008

    • Author(s)
      渡部琢也・有田茂子・本郷茂樹・宮崎章
    • Organizer
      第81回日本生化学会大会、第31回日本分子生物学会年会合同大会
    • Place of Presentation
      神戸
    • Year and Date
      20081200
  • [Presentation] Preventive effects of heregulin-β1 on macrophage foam cell formation and atherosclerosis.2008

    • Author(s)
      Watanabe T, Arita S, Hongo S, Miyazaki A, 他
    • Organizer
      American Heart Association Scientific Sessions 2008
    • Place of Presentation
      New Orleans
    • Year and Date
      20081100
  • [Presentation] 血漿ウロテンシンII(UII)濃度の増加と糖尿病性網膜症および頸動脈硬化との関連2008

    • Author(s)
      勝呂俊昭・渡部琢也・宮崎章・平野勉, 他
    • Organizer
      第40回日本動脈硬化学会学術集会
    • Place of Presentation
      つくば
    • Year and Date
      20080700
  • [Presentation] ウロテンシンIIの血中レベルの増加は血管性認知症の危険因子である2008

    • Author(s)
      伴良行・渡部琢也・宮崎章・他
    • Organizer
      第40回日本動脈硬化学会学術集会
    • Place of Presentation
      つくば
    • Year and Date
      20080700
  • [Presentation] ヒト単球由来マクロファージの泡沫化に対するサリューシンαおよびβの相反作用2008

    • Author(s)
      宮崎章・本郷茂樹・渡部琢也
    • Organizer
      第50回日本脂質生化学会
    • Place of Presentation
      徳島
    • Year and Date
      20080600
  • [Presentation] 血漿ウロテンシンII(UII)濃度の増加と糖尿病性網膜症との関連2008

    • Author(s)
      勝呂俊昭・渡部琢也・宮崎 章・平野勉・他
    • Organizer
      第51回日本糖尿病学会年次学術集会
    • Place of Presentation
      東京
    • Year and Date
      20080500
  • [Presentation] ウロテンシンIIの血中レベルの増加は血管性認知症の危険因子である2008

    • Author(s)
      伴良行・渡部琢也・宮崎章・他
    • Organizer
      第51回日本糖尿病学会年次学術集会
    • Place of Presentation
      東京
    • Year and Date
      20080500

URL: 

Published: 2012-01-26   Modified: 2013-06-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi